Tuesday, April 21, 2015

Public Release: 21-Apr-2015 Trial shows benefit of 'BRCA-targeting' drug in ... - EurekAlert (press release)


Business Insider

Public Release: 21-Apr-2015 Trial shows benefit of 'BRCA-targeting' drug in ...
EurekAlert (press release)
Men with prostate cancer benefit from treatment with the pioneering drug olaparib - the first cancer drug to target inherited mutations - according to the results of a major trial presented today (Tuesday). Olaparib was licensed in December for women with ...
Posted by Shoaib-ur-Rehman SiddiquiBusiness Recorder (press release) (blog)

all 9 news articles »

http://ift.tt/1b6acB9
by via Health - Google News

No comments:

Post a Comment

Medicalia.org

Medicalia.org
developed by Internet Medical Society